1. Lanctot KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, et al. Neuropsychiatric signs and symptoms of Alzheimer’s disease: new treatment paradigms. Alzheimers Dement (NY) 2017;3:440–449.
2. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000;157:708–714.
3. Peters KR, Rockwood K, Black SE, Bouchard R, Gauthier S, Hogan D, et al. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics. Neurology 2006;66:23–528.
4. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475–1483.
6. Germain S, Adam S, Olivier C, Cash H, Ousset PJ, Andrieu S, et al. Does cognitive impairment influence burden in caregivers of patients with Alzheimer’s disease? J Alzheimers Dis 2009;17:105–114.
8. Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, et al. Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry 2014;22:1168–1179.
9. Guercio BJ, Donovan NJ, Ward A, Schultz A, Lorius N, Amariglio RE, et al. Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J Neuropsychiatry Clin Neurosci 2015;27:e22–e27.
10. Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL. Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol 2007;64:1015–1020.
11. Robert PH, Darcourt G, Koulibaly MP, Clairet S, Benoit M, Garcia R, et al. Lack of initiative and interest in Alzheimer’s disease: a single photon emission computed tomography study. Eur J Neurol 2006;13:729–735.
12. Cacciari C, Moraschi M, Di Paola M, Cherubini A, Orfei MD, Giove F, et al. White matter microstructure and apathy level in amnestic mild cognitive impairment. J Alzheimers Dis 2010;20:501–507.
13. Jonsson M, Edman A, Lind K, Rolstad S, Sjogren M, Wallin A. Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia. Int J Geriatr Psychiatry 2010;25:588–595.
14. Balthazar ML, Pereira FR, Lopes TM, da Silva EL, Coan AC, Campos BM, et al. Neuropsychiatric symptoms in Alzheimer’s disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp 2014;35:1237–1246.
15. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005;25:7709–7717.
16. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008;1124:1–38.
17. Raichle ME. The brain’s default mode network. Annu Rev Neurosci 2015;38:433–447.
18. Damoiseaux JS, Prater KE, Miller BL, Greicius MD. Functional connectivity tracks clinical deterioration in Alzheimer’s disease. Neurobiol Aging 2012;33:828.e19–828.e30.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
20. Kang Y, Na DL, Han S. A validity study of the Korean mini-mental state examination in dementia patients. J Korean Neurol Assoc 1997;15:300–308.
21. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412–2414.
23. Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, et al. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord 2007;24:457–463.
25. Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci 2011;15:483–506.
28. Amodio DM, Frith CD. Meeting of minds: the medial frontal cortex and social cognition. Nat Rev Neurosci 2006;7:268–277.
29. Rolland Y, Payoux P, Lauwers-Cances V, Voisin T, Esquerre JP, Vellas B. A SPECT study of wandering behavior in Alzheimer’s disease. Int J Geriatr Psychiatry 2005;20:816–820.
30. Bruen PD, McGeown WJ, Shanks MF, Venneri A. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 2008;131:2455–2463.
32. Hayata TT, Bergo FP, Rezende TJ, Damasceno A, Damasceno BP, Cendes F, et al. Cortical correlates of affective syndrome in dementia due to Alzheimer’s disease. Arq Neuropsiquiatr 2015;73:553–560.